News

Cancer’s future may lie in combination therapy—pairing treatments to outsmart tumors, boost survival, and bring new hope ...
There’s a new twist in the fight against bladder cancer — and it’s delivering game-changing results. In a recent clinical ...
Personalized vaccines are currently being investigated for the treatment of patients with kidney cancer; however, the ...
When Robert Stone thinks about what makes City of Hope stand apart, it's the people. He recalls a patient who stopped him, a ...
Art Sullivan, a 38-year-old Ironman athlete, and Josh Lehman, 48, who works at the University of Rochester, are connected by ...
ANSWER: Gynecomastia is the growth of male breast tissue, specifically when not due to breast cancer. It can happen during ...
A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with ...
What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...
Research has shown that there is a high rate of cannabis use among cancer patients — more than 50% in some studies, and up to ...
Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') announced the enrollment and dosing of the first patient in the pivotal Phase III clinical trial (AK104-310/COMPASSION-33) evaluating cadonilimab, a ...
The biotechnology company said late Monday that Health Canada issued a Notice of Compliance with Conditions for its treatment, Amtagvi, for adult patients with unresectable or metastatic melanoma that ...
Katie Monin, a Seattle lawyer and mother of two young children, chose proton therapy as part of her treatment for brain ...